Standout Papers

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activatin... 2004 2026 2011 2018 3.5k
  1. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling (2007)
    Jeffrey A. Engelman, Kreshnik Zejnullahu et al. Science
  2. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer (2005)
    Scott A. Tomlins, Daniel R. Rhodes et al. Science
  3. Detection of large-scale variation in the human genome (2004)
    A. John Iafrate, Lars Feuk et al. Nature Genetics
  4. Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes (2007)
    Barbara E. Stranger, Matthew S. Forrest et al. Science
  5. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma (2005)
    Levi A. Garraway, Hans R. Widlund et al. Nature
  6. Diet and the evolution of human amylase gene copy number variation (2007)
    George H. Perry, Nathaniel J. Dominy et al. Nature Genetics
  7. Copy number variation: New insights in genome diversity (2006)
    Jennifer L. Freeman, George H. Perry et al. Genome Research
  8. Common deletion polymorphisms in the human genome (2005)
    Steven A. McCarroll, Tracy N. Hadnott et al. Nature Genetics
  9. Landscape of Somatic Retrotransposition in Human Cancers (2012)
    Eunjung Lee, Rebecca C. Iskow et al. Science
  10. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs (2008)
    Joshua M. Korn, Finny G. Kuruvilla et al. Nature Genetics
  11. Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor (2024)
    Yun-Jae Kim, Gihyeon Kim et al. Cell Host & Microbe

Immediate Impact

4 by Nobel laureates 50 from Science/Nature 93 standout
Sub-graph 1 of 17

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
3 intermediate papers

Works of Charles Lee being referenced

Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
2010
Phase II Trial of Thalidomide for Therapy of Radioiodine-Unresponsive and Rapidly Progressive Thyroid Carcinomas
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
Charles Lee 14336 8619 5804 304 27.3k
Richard K. Wilson 17312 7110 5758 217 29.7k
Thomas Ried 17403 6100 7182 375 27.3k
Michael R. Speicher 9727 4136 5581 173 18.6k
Paul S. Meltzer 22087 5212 9027 378 35.0k
Elaine R. Mardis 23825 6927 9985 297 42.8k
Olli Kallioniemi 19874 9262 9579 419 35.7k
Jeffrey M. Trent 20147 5993 7246 377 30.9k
Jerry W. Shay 34712 5090 8781 512 56.7k
Peter Lichter 19212 7104 6660 488 36.0k
D.N. Cooper 19458 10199 2051 560 33.9k

All Works

Loading papers...

Rankless by CCL
2026